161 related articles for article (PubMed ID: 32889249)
21. Is resection of pancreatic adenocarcinoma with synchronous hepatic metastasis justified? A review of current literature.
Antoniou E; Margonis GA; Sasaki K; Andreatos N; Polychronidis G; Pawlik TM; Pikoulis E
ANZ J Surg; 2016 Dec; 86(12):973-977. PubMed ID: 27580713
[TBL] [Abstract][Full Text] [Related]
22. Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.
Park JB; Kim YH; Kim J; Chang HM; Kim TW; Kim SC; Kim PN; Han DJ
J Vasc Interv Radiol; 2012 May; 23(5):635-41. PubMed ID: 22525021
[TBL] [Abstract][Full Text] [Related]
23. [Impact of time of occurrence of liver metastases (synchronous vs. metachronous) on early postoperative outcome and long-term survival of colorectal cancer patients].
Bova R; Kamphues C; Neuhaus P; Puhl G
Zentralbl Chir; 2014 Apr; 139(2):220-5. PubMed ID: 23846535
[TBL] [Abstract][Full Text] [Related]
24. Oncologic resection of pancreatic cancer with isolated liver metastasis: Favorable outcomes in select patients.
Nagai M; Wright MJ; Ding D; Thompson ED; Javed AA; Weiss MJ; Hruban RH; Yu J; Burkhart RA; He J; Cameron JL; Wolfgang CL; Burns WR
J Hepatobiliary Pancreat Sci; 2023 Aug; 30(8):1025-1035. PubMed ID: 36652559
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of additive chemotherapy after curative resection of metachronous colorectal liver metastasis: a single-centre retrospective study.
Kelm M; Schollbach J; Anger F; Wiegering A; Klein I; Germer CT; Schlegel N; Kunzmann V; Löb S
BMC Cancer; 2021 May; 21(1):490. PubMed ID: 33941104
[TBL] [Abstract][Full Text] [Related]
27. Surgical resection of metachronous hepatic metastases from gastric cancer improves long-term survival: A population-based study.
Li SC; Lee CH; Hung CL; Wu JC; Chen JH
PLoS One; 2017; 12(7):e0182255. PubMed ID: 28759654
[TBL] [Abstract][Full Text] [Related]
28. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959
[TBL] [Abstract][Full Text] [Related]
29. Surgical treatment of metastatic pancreatic ductal adenocarcinoma: A review of current literature.
Sakaguchi T; Valente R; Tanaka K; Satoi S; Del Chiaro M
Pancreatology; 2019 Jul; 19(5):672-680. PubMed ID: 31285145
[TBL] [Abstract][Full Text] [Related]
30. Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes.
Nguyen KT; Laurent A; Dagher I; Geller DA; Steel J; Thomas MT; Marvin M; Ravindra KV; Mejia A; Lainas P; Franco D; Cherqui D; Buell JF; Gamblin TC
Ann Surg; 2009 Nov; 250(5):842-8. PubMed ID: 19806058
[TBL] [Abstract][Full Text] [Related]
31. Liver resection for non-colorectal non-neuroendocrine metastases.
Clarke NAR; Kanhere HA; Trochsler MI; Maddern GJ
ANZ J Surg; 2018 Apr; 88(4):E313-E317. PubMed ID: 27490345
[TBL] [Abstract][Full Text] [Related]
32. Factors influencing receipt of adjuvant chemotherapy after surgery for pancreatic cancer: a two-center retrospective cohort study.
Åkerberg D; Björnsson B; Ansari D
Scand J Gastroenterol; 2017 Jan; 52(1):56-60. PubMed ID: 27598522
[TBL] [Abstract][Full Text] [Related]
33. Factors influencing survival after hepatectomy for metastases from gastric cancer.
Tiberio GA; Ministrini S; Gardini A; Marrelli D; Marchet A; Cipollari C; Graziosi L; Pedrazzani C; Baiocchi GL; La Barba G; Roviello F; Donini A; de Manzoni G;
Eur J Surg Oncol; 2016 Aug; 42(8):1229-35. PubMed ID: 27134189
[TBL] [Abstract][Full Text] [Related]
34. Successful outcome after resection of pancreatic cancer with a solitary hepatic metastasis.
Shimada K; Kosuge T; Yamamoto J; Yamasaki S; Sakamoto M
Hepatogastroenterology; 2004; 51(56):603-5. PubMed ID: 15086214
[TBL] [Abstract][Full Text] [Related]
35. Pathological and Radiological Splenic Vein Involvement are Predictors of Poor Prognosis and Early Liver Metastasis After Surgery in Patients with Pancreatic Adenocarcinoma of the Body and Tail.
Mizumoto T; Toyama H; Asari S; Terai S; Mukubo H; Yamashita H; Shirakawa S; Nanno Y; Ueda Y; Sofue K; Tanaka M; Kido M; Ajiki T; Fukumoto T
Ann Surg Oncol; 2018 Mar; 25(3):638-646. PubMed ID: 29264672
[TBL] [Abstract][Full Text] [Related]
36. Laparoscopic liver resection compared to open approach in patients with colorectal liver metastases improves further resectability: Oncological outcomes of a case-control matched-pairs analysis.
Montalti R; Berardi G; Laurent S; Sebastiani S; Ferdinande L; Libbrecht LJ; Smeets P; Brescia A; Rogiers X; de Hemptinne B; Geboes K; Troisi RI
Eur J Surg Oncol; 2014 May; 40(5):536-544. PubMed ID: 24555996
[TBL] [Abstract][Full Text] [Related]
37. The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis.
Mackay TM; Smits FJ; Roos D; Bonsing BA; Bosscha K; Busch OR; Creemers GJ; van Dam RM; van Eijck CHJ; Gerhards MF; de Groot JWB; Groot Koerkamp B; Haj Mohammad N; van der Harst E; de Hingh IHJT; Homs MYV; Kazemier G; Liem MSL; de Meijer VE; Molenaar IQ; Nieuwenhuijs VB; van Santvoort HC; van der Schelling GP; Stommel MWJ; Ten Tije AJ; de Vos-Geelen J; Wit F; Wilmink JW; van Laarhoven HWM; Besselink MG;
HPB (Oxford); 2020 Feb; 22(2):233-240. PubMed ID: 31439478
[TBL] [Abstract][Full Text] [Related]
38. Significance of pulmonary resection in patients with metachronous pulmonary metastasis from pancreatic ductal adenocarcinoma: a retrospective cohort study.
Mashiko T; Nakano A; Masuoka Y; Yamamoto S; Ozawa S; Nakagohri T
BMC Surg; 2021 May; 21(1):237. PubMed ID: 33952223
[TBL] [Abstract][Full Text] [Related]
39. "Cherry picking", a multiple non-anatomic liver resection technique, as a promising option for diffuse liver metastases in patients with neuroendocrine tumours.
Krausch M; Raffel A; Anlauf M; Schott M; Lehwald N; Krieg A; Topp SA; Cupisti K; Knoefel WT
World J Surg; 2014 Feb; 38(2):392-401. PubMed ID: 24101025
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous versus staged resection for synchronous colorectal liver metastases: A population-based cohort study.
Bogach J; Wang J; Griffiths C; Parpia S; Saskin R; Hallet J; Ruo L; Simunovic M; Serrano PE
Int J Surg; 2020 Feb; 74():68-75. PubMed ID: 31843676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
